Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,044 USD | +0.51% |
|
+1.74% | +18.91% |
18/06 | Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma | MT |
17/06 | Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.91% | 11TCr | |
+15.85% | 12TCr | |
+7.37% | 2.28TCr | |
-18.63% | 2.07TCr | |
-13.76% | 1.64TCr | |
-15.66% | 1.65TCr | |
-43.53% | 1.58TCr | |
+1.75% | 1.35TCr | |
+28.07% | 1.17TCr | |
+108.81% | 1.04TCr |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals Says GN7075 Plus Libtayo Shows Anti-Tumor Responses in Microsatellite Stable Colorectal Cancer